Literature DB >> 23002170

The effect of transcatheter arterial chemoembolization on hepatitis C viremia.

Parag Mahale, Ahmed Kaseb, Marta Davila, Harrys A Torres.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23002170      PMCID： PMC3448418          DOI： 10.1634/theoncologist.2012-0187

Source DB:  PubMed          Journal:  Oncologist        ISSN： 1083-7159


× No keyword cloud information.
  10 in total

1.  Hepatitis B virus reactivation after a single session of transarterial chemoembolization in patients with hepatocellular carcinoma.

Authors:  Giovan B Vizzini; Angelo Luca; Ignazio R Marino
Journal:  Ann Intern Med       Date:  2003-04-15       Impact factor: 25.391

Review 2.  Chemoembolization for primary and metastatic liver cancer.

Authors:  Eleni Liapi; Jean-Francois H Geschwind
Journal:  Cancer J       Date:  2010 Mar-Apr       Impact factor: 3.360

Review 3.  Reactivation of hepatitis B virus and hepatitis C virus in patients with cancer.

Authors:  Harrys A Torres; Marta Davila
Journal:  Nat Rev Clin Oncol       Date:  2012-01-24       Impact factor: 66.675

4.  Risk of hepatitis B exacerbation is low after transcatheter arterial chemoembolization therapy for patients with HBV-related hepatocellular carcinoma: report of a prospective study.

Authors:  Joong-Won Park; Kyung Woo Park; Sang Hyung Cho; Hong Suk Park; Woo Jin Lee; Do Hoon Lee; Chang-Min Kim
Journal:  Am J Gastroenterol       Date:  2005-10       Impact factor: 10.864

5.  Serum HIF-1alpha and VEGF levels pre- and post-TACE in patients with primary liver cancer.

Authors:  Zhong-zhi Jia; Guo-min Jiang; Yao-liang Feng
Journal:  Chin Med Sci J       Date:  2011-09

6.  Transarterial chemoembolization plus sorafenib: a sequential therapeutic scheme for HCV-related intermediate-stage hepatocellular carcinoma: a randomized clinical trial.

Authors:  Domenico Sansonno; Gianfranco Lauletta; Sabino Russi; Vincenza Conteduca; Loredana Sansonno; Franco Dammacco
Journal:  Oncologist       Date:  2012-02-14

7.  Transarterial chemo-lipiodolization can reactivate hepatitis B virus replication in patients with hepatocellular carcinoma.

Authors:  Jeong Won Jang; Jong Young Choi; Si Hyun Bae; Chang Wook Kim; Seung Kew Yoon; Se Hyun Cho; Jin Mo Yang; Byung Min Ahn; Chang Don Lee; Young Sok Lee; Kyu Won Chung; Hee Sik Sun
Journal:  J Hepatol       Date:  2004-09       Impact factor: 25.083

8.  Improving the diagnosis of acute hepatitis C virus infection with expanded viral load criteria.

Authors:  Barbara H McGovern; Christopher E Birch; Melinda J Bowen; Laura L Reyor; Ellen H Nagami; Raymond T Chung; Arthur Y Kim
Journal:  Clin Infect Dis       Date:  2009-10-01       Impact factor: 9.079

9.  A dual role for hypoxia inducible factor-1α in the hepatitis C virus lifecycle and hepatoma migration.

Authors:  Garrick K Wilson; Claire L Brimacombe; Ian A Rowe; Gary M Reynolds; Nicola F Fletcher; Zania Stamataki; Ricky H Bhogal; Maria L Simões; Margaret Ashcroft; Simon C Afford; Ragai R Mitry; Anil Dhawan; Christopher J Mee; Stefan G Hübscher; Peter Balfe; Jane A McKeating
Journal:  J Hepatol       Date:  2011-12-16       Impact factor: 25.083

10.  Fulminant hepatitis on withdrawal of chemotherapy in carriers of hepatitis C virus.

Authors:  S Vento; F Cainelli; F Mirandola; L Cosco; G Di Perri; M Solbiati; T Ferraro; E Concia
Journal:  Lancet       Date:  1996-01-13       Impact factor: 79.321
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.